Target intelligence / Profile preview

Cubilin-amnionless receptor complex (Cubam)

Target
Cubam
Molecular classification
Receptor, Multi-ligand receptor, Endocytic receptor
01

Overview

The Cubilin-amnionless receptor complex, commonly known as Cubam, is a multimeric endocytic receptor essential for the absorption of specific ligands in the intestine and kidney [1, 3]. It is composed of two primary subunits: cubilin, which provides the ligand-binding domains, and amnionless, which anchors the complex to the plasma membrane and initiates endocytosis [2, 5]. In the terminal ileum, Cubam is the sole receptor responsible for the uptake of the intrinsic factor-vitamin B12 complex, a process vital for maintaining systemic cobalamin levels [1, 4]. In the renal proximal tubules, the complex facilitates the reabsorption of various proteins from the glomerular filtrate, including albumin and transferrin, to prevent proteinuria [3, 4]. Mutations in the genes encoding either subunit result in Imerslund-Gräsbeck syndrome, characterized by megaloblastic anemia and persistent proteinuria [1, 6]. While not a typical target for pharmacological inhibition, Cubam is the primary pathway for the therapeutic administration of oral vitamin B12 [8]. Furthermore, its role in protein trafficking makes it a subject of interest for targeted drug delivery and a potential biomarker for renal health and certain malignancies [2, 4].

Other names
Cubam receptorIntrinsic factor-vitamin B12 receptorIF-B12 receptorCubilin-amnionless complexCUBN-AMN complex
02

Mechanism of action

The receptor complex facilitates the receptor-mediated endocytosis of the intrinsic factor-vitamin B12 complex in the ileum and the reabsorption of low-molecular-weight proteins in the renal proximal tubules [1, 3, 4].

03

Biological functions

Vitamin B12 absorptionRenal protein reabsorptionEndocytosisLigand binding
04

Disease associations

Imerslund-Gräsbeck syndromeMegaloblastic anemiaProteinuriaVitamin B12 deficiency
05

Safety considerations

Vitamin B12 malabsorptionChronic proteinuriaNeurological deterioration due to cobalamin deficiency
06

Interacting drugs

Cyanocobalamin

1 more in the full profile.

07

Biomarkers

CUBN gene mutationsAMN gene mutationsUrinary albumin levelsSerum vitamin B12 levels

Beyond the preview

Go deeper on Cubilin-amnionless receptor complex (Cubam).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cubilin-amnionless receptor complex (Cubam).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call